Molly Yancovitz, M.D.

Instructor in Otolaryngology, Harvard Medical School

Instructor in Dermatology, Harvard Medical School



Board Certification

  • Dermatology

Main Campus
243 Charles Street
Boston, MA 02114
Phone: 617-573-3789
Fax: 617-573-3727
Tuesdays, Thursdays, and Fridays from 8am to 4:30pm. Wednesdays from 8am to 12pm.



Specializing in Mohs surgery and treating patients with skin cancer, Dr. Molly Yancovitz is an accomplished dermatologic surgeon for Mass. Eye and Ear’s Facial and Cosmetic Surgery Center. She received her medical degree from the University of California, San Francisco School of Medicine, where she graduated with honors and was elected to the Alpha Omega Alpha medical honor society. She then completed her internal medicine internship at Columbia University Medical School prior to completing her residency in dermatology and a melanoma translational research fellowship at New York University School of Medicine. Subsequently, she completed a Mohs surgery fellowship under David S. Becker, M.D., approved by the American College of Mohs Surgery. Now, she is the Co-Director of the Mass. Eye and Ear Multidisciplinary Cutaneous Oncology Center and is an Instructor in Otolaryngology at Harvard Medical School.

A board-certified dermatologist, Dr. Yancovitz has been an invited speaker at regional and national meetings, and has published several peer-reviewed papers in the field. She is a fellow of the American Academy of Dermatology and the American College of Mohs Surgery. Additionally, she is a member of the American Society of Dermatologic Surgery and the New England Dermatological Society.

Dr. Yancovitz’s clinical interests include skin cancer, Mohs surgery, and dermatologic surgery. Her research interests include non-melanoma and melanoma skin cancers.

Patient perceptions of nonmelanoma skin cancer before diagnosis. Yancovitz M, Rizzo C, Julian P, Oliveria SA, Becker D. Dermatol Surg. 2013 Oct. 39(10):1496-501.

Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. Yancovitz M, Litterman A, Yoon J, Ng E, Shapiro RL, Berman RS, Pavlick AC, Darvishian F, Christos P, Mazumdar M, Osman I, Polsky D. PLoS One. 2012. 7(1):e29336.

Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto V, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D. Arch Dermatol. 2008 Apr. 144(4):469-74.

Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma. Yancovitz M, Finelt N, Warycha MA, Christos PJ, Mazumdar M, Shapiro RL, Pavlick AC, Osman I, Polsky D, Berman RS. Cancer. 2007 Sep 1. 110(5):1107-14.
PubMed PMID: 17620286.

Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma. Yancovitz M, Yoon J, Mikhail M, Gai W, Shapiro RL, Berman RS, Pavlick AC, Chapman PB, Osman I, Polsky D. J Mol Diagn. 2007 Apr. 9(2):178-83.

A complete list of research publications can be seen at Type the physician's name at the top, where it says 'for' and the physician's research publications will appear.



  • University of California, San Francisco, M.D.


  • Columbia University Medical Center


  • New York University


  • Melanoma Translational Research Fellowship, New York University
  • Mohs Surgery, David S. Becker, M.D., P.C., New York, NY